Page 118 - MEMORIA ANUAL 2020

GRUPO ESPAÑOL DE TRASPLANTE HEMATOPOYÉTICO (GETH)
MEMORIA ANUAL 2020 SOCIEDAD ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA
FUNDACIÓN ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA
Pósteres
Congresos internacionales
• Isavuconazole in allogeneic stem cell transplantation. A real-life report from the Spanish Group of Transplant and Cellular Therapy (GETH).
EHA 2020.
Oarbeascoa G, Sánchez Salinas M, Bailén R, Dorado N, Pérez A, Hernani R, Arzuaga A, Gómez Centurión I, Diez-Martín JL, Kwon M.
• NKG2D CAR T cells are not affected by soluble NKG2D ligands. EBMT 2020.
Fernández A, et al.
• Post-transplant cyclophosphamide after matched sibling and matched unrelated compared to haploidentical donor transplants in patients with acute myeloid leukemia, a study on behalf of GETH (ID: 392).
EBMT 2020.
Kwon M, Bailén R, Pascual Cascón M, López Corral L, Bermúdez A, Herrera P, Sampol A, Heras I, Martín Calvo C, Sanz J, Sánchez-Ortega I, Torres M, Rifón Roca J, Humala K, Muñoz C, Gómez Centurión I, Oarbeacoa G, Dorado N, Díez-Martín J.
• Defibrotide in HSCT: an study of Grupo Español de Trasplante Hematopoyético (GETH/ GETMON).
EBMT 2020.
• Outcome after transplant in children with JMML (GETH). EBMT 2020.
• Investigation of virological features and clinical outcomes associated with pre-engraftment cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplantation recipients. EBMT 2020.
Solano C, et al.
118